Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients
Irazu Oncology has raised $250K in total funding. The most recent round was Undisclosed. The last funding was announced in July 2026.
Irazu Oncology's investors include TEDCO.
Irazu Oncology is headquartered in Baltimore, United States.
Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients
Irazu Oncology is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Irazu Oncology — Funding & Investors." VCBacked, July 7, 2026, https://www.vcbacked.co/company/irazu-oncology. Accessed September 15, 2026.
VCBacked. (2026). Irazu Oncology — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/irazu-oncology
{{cite web |title=Irazu Oncology — Funding & Investors |url=https://www.vcbacked.co/company/irazu-oncology |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated